Printer Friendly
The Free Library
19,573,962 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Company Profile for InforMedix, Inc.


InforMedix has developed the Med-eMonitor System to provide real-time 1. real-time - Describes an application which requires a program to respond to stimuli within some small upper limit of response time (typically milli- or microseconds). Process control at a chemical plant is the classic example.  medical management and patient communications for clinical drug trials. The Company has integrated a portable patient-interactive monitoring device, hardware, software and networked communications system In telecommunication, a communications system is a collection of individual communications networks, transmission systems, relay stations, tributary stations, and data terminal equipment (DTE) usually capable of interconnection and interoperation to form an integrated whole.  to enable pharmaceutical and biotechnology companies Top 100 Biotechnology Companies
The following is a list of the top 100 biotechnology companies ranked by revenue. The first nine companies qualify for the list of the top 50 pharmaceutical companies.
, and medical researchers to efficiently monitor and manage patients' medication medication /med·i·ca·tion/ (med?i-ka´shun)
1. medicine (1).

2. impregnation with a medicine.

3. administration of a medicine or other remedy.
 compliance, protocol adherence adherence /ad·her·ence/ (ad-her´ens) the act or condition of sticking to something.

immune adherence
, clinical response, and safety. Med-eMonitor is specifically designed to improve patient medication compliance and protocol adherence in clinical drug trials. InforMedix's strong intellectual property consists of 15 issued patents and 14 patents pending. The Company's patents have been cited as prior art by patent examiners A patent examiner or patent clerk is an employee, usually a civil servant, working within a patent office. Major employers of patent examiners are the European Patent Office (EPO), the United States Patent and Trademark Office (USPTO) and the Japan Patent Office.  in over 150 other issued patents.
Company:                InforMedix, Inc.

    Headquarters Address:   5580 Hobbard Drive
                            Rockville, MD 20852

    Main Telephone:         301-984-1566

    Website:                www.informedix.com

    Ticker:                 IFMX (OTCBB)

    Type of Organization:   Public

    Industry:               Health

    Key Executives:         Chairman and CEO: Bruce A. Kehr, M.D.
                            President and COO: Janet Campbell
                            CFO: Arthur T. Healey

    Public Relations
     Contact:               Tina Wilmott
     Phone:                 858-450-0030
     Email:                 twilmott@mcquerter.com

COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jul 2, 2004
Words:160
Previous Article:Company Profile for Virtual Compute Corporation.
Next Article:Company Profile for Silver State Helicopters LLC.



Related Articles
Med-eMonitor's Growing Role in ePRO Profiled in Empire Magazine.
Informedix Listed on Berlin Stock Exchange.
Dr. Alexander Miller Joins InforMedix Scientific Advisory Board.
InforMedix, Inc. Announces Conference Call to Discuss Recent Developments.
InforMedix, Inc. Adjourns Annual Meeting.
InforMedix and McKesson BioServices to Provide Clinical Study Services for Diabetic Patients at St. Vincent Healthcare.
InforMedix Vice President is Promoted, Additional Sales Staff to Be Recruited.
InforMedix and McKesson BioServices Co-Present Their Integrated Technology Platform for Clinical Studies at CSSG Conference.
InforMedix Expands Agreement with Enhanced Care Initiatives to Include Texas.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles